The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Travel, Accommodations, Expenses - Abbvie
A phase 2 randomized study of telisotuzumab adizutecan (ABBV-400, Temab-A) in combination with standard of care (SOC) in patients with metastatic colorectal cancer.
 
Ardaman Shergill
Honoraria - Biyantara Foundation; Cholangiocarcinoma Foundation; Colon Cancer Alliance; Colon Cancer alliance; Great Debates in GI cancers
Consulting or Advisory Role - Guardant Health; Ipsen; Iterion Therapeutics; Merus; Pfizer; Pfizer; Revolution Medicines; Takeda
Research Funding - Abbvie (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); BMS (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Gossamer Bio (Inst); Gritstone Bio (Inst); Hutchison MediPharma (Inst); Macrogenics (Inst); Merck (Inst); Oncologie (Inst); Pfizer (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst); Seattle Genetics/Astellas (Inst); Takeda (Inst); TP Therapeutics (Inst); verastem (Inst)
Travel, Accommodations, Expenses - colon cancer alliance; Ipsen; Merus; Revolution Medicines; Takeda
 
Michael Cecchini
Stock and Other Ownership Interests - Parthenon Therapeutics
Honoraria - Abbvie; Agenus; Arcus Biosciences; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Cybrexa Therapeutics; Daiichi Sankyo/Astra Zeneca; DAVA Pharmaceuticals; Elevation Oncology; Incendia Therapeutics; Incyte; Loxo/Lilly; Macrogenics; Modifi Bio; Parabalis; Regeneron; Seagen; Taiho Oncology; Wren Therapeutics
 
Gerald Prager
Consulting or Advisory Role - Amgen; Arcus Biosciences; Astellas Pharma; AstraZeneca; Bayer; BMSi; Merck Serono; MSD; Pierre Fabre; Roche/Genentech; SERVIER; Taiho Oncology; Takeda
 
Stacey Cohen
Consulting or Advisory Role - Abbvie; Agenus; Caris Life Sciences; DoMore Diagnostics; Exact Sciences; GlaxoSmithKline; Guardant Health; Incyte; Janssen; Merck; Pfizer; Roche Molecular Diagnostics
Research Funding - Biomea (Inst); BioNTech SE (Inst); Natera (Inst); Pfizer (Inst); Tempus (Inst)
Expert Testimony - Brewster & DeAngelis; Mac Ban; Power Rogers; The Cline Law Firm
 
Akihito Kawazoe
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Abbvie; GlaxoSmithKline; MSD; Revolution Medicines; Zymeworks
Speakers' Bureau - Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Stephanie Wu
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie; Genentech/Roche
 
Kunal Desai
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Travel, Accommodations, Expenses - Abbvie
 
Martha Neagu Aristide
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Patents, Royalties, Other Intellectual Property - Am on patent applications for IAs I worked on at AbbVie (Inst)
 
Apurvasena Parikh
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Athanasios Vasilopoulos
No Relationships to Disclose
 
Yunxia Sui
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Yu Sunakawa
Honoraria - Astellas Pharma; AstraZeneca; Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Guardant Health; Incyte; Lilly Japan; Merck; MSD K.K; Ono Pharmaceutical; Sysmex; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Daiichi Sankyo; Merck; MSD K.K; Ono Pharmaceutical
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); ICON Clinical Research (Inst); IQvia (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)